FindTrial
Sign In

Erbitux

DRUG7 trials

Sponsors

ARCAGY/ GINECO GROUP, Dana-Farber Cancer Institute, Hellenic Oncology Research Group, Intergroupe Francophone de Cancerologie Thoracique, Groupe Oncologie Radiotherapie Tete et Cou

Conditions

Adenosquamous Cell CarcinomaBarrett Oesophagitis With DysplasiaBarrett's Esophagus Without DysplasiaBasaloid Squamous Cell CarcinomaCervix CancerColorectal CancerEsophageal AdenocarcinomaHead and Neck Cancer

Phase 1

Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
TerminatedNCT00570674
Dana-Farber Cancer InstituteAdenosquamous Cell Carcinoma, Basaloid Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck +1
Start: 2007-11-30End: 2013-10-31Updated: 2017-11-13

Phase 2

Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epithelial Cancer of the Cervix
TerminatedNCT00518193
ARCAGY/ GINECO GROUPCervix Cancer
Start: 2007-04-30End: 2008-09-30Updated: 2011-06-30
Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer
TerminatedNCT00681876
Hellenic Oncology Research GroupColorectal Cancer
Start: 2008-04-30End: 2010-02-28Updated: 2013-02-13
Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)
CompletedNCT01102231
Intergroupe Francophone de Cancerologie ThoraciqueStage III Non-small Cell Lung Cancer
Start: 2010-03-31End: 2015-12-31Updated: 2021-02-16
Reirradiation and Erbitux in the HNSCC
CompletedNCT01237483
Groupe Oncologie Radiotherapie Tete et CouHead and Neck Cancer Squamous Cell
Start: 2010-10-31End: 2016-07-05Updated: 2017-10-26
Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma
TerminatedNCT01794845
University of MiamiHead and Neck Cancer, Recurrent Disease, Squamous Cell Carcinoma
Start: 2013-06-03End: 2016-06-07Updated: 2017-05-11
Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas
RecruitingNCT05745857
University Medical Center GroningenBarrett Oesophagitis With Dysplasia, Barrett's Esophagus Without Dysplasia, Esophageal Adenocarcinoma
Start: 2023-09-15End: 2026-12-01Target: 25Updated: 2026-04-13

Related Papers

Phase II study of cetuximab, pemetrexed, cisplatin and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small cell lung cancer (NSCLC): Results of the IFCT-0803 trial.
Journal of Clinical Oncology2014-05-201 citations